Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Reckitt Benckiser Says No Longer in Talks to Buy Merck Unit

April 30 (Bloomberg) -- Reckitt Benckiser Group Plc said it’s no longer in active talks to buy the consumer-health arm of Merck & Co., saying the purchase doesn’t meet its investment criteria.

“We are a highly disciplined acquirer with strict return metrics, which we will not break,” Reckitt Benckiser Chief Executive Officer Rakesh Kapoor said in an e-mailed statement today. “The consumer health market remains highly fragmented and we will continue to evaluate opportunities that fit both our strategic and financial criteria.”

Bayer AG is proposing a deal for the unit that could include some of the German company’s health-care assets in addition to paying cash, people familiar with the matter said. Reckitt Benckiser said on April 28th that it was in talks with Merck.

Link to Company News:{RB/ LN <Equity> CN <GO>} Link to Company News:{MRK US <Equity> CN <GO>} Link to Company News:{BAYN GR <Equity> CN <GO>}

To contact the reporter on this story: Celeste Perri in Amsterdam at

To contact the editor responsible for this story: Celeste Perri at

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.